Blockchain Technology in Healthcare Market Trends, Key Players and Future Scope

Global Blockchain Technology in Healthcare Market to Reach $890.5 Million by 2023

ŠP&SIntelligence.Allrightsreserved

1

Due to the increasing number of policies and regulations implemented in several countries for securing consumer data, surging investments being made in blockchain technology, and the adoption of blockchain solutions in the pharmaceuticals supply chains, the global blockchain in healthcare market will grow from $44.6 million to $890.5 million from 2017 to 2023. The market is also predicted to demonstrate a CAGR of over 67.1% between 2018 and 2023, according to the estimates of the market research company, P&S Intelligence.

A major factor boosting the growth of the blockchain in healthcare market is the increasing measures and regulations being enacted by the governments of many countries for safeguarding consumer information. For instance, a new data protection policy was implemented by the European Union (EU) in 2018 called ‘the General Data Protection Regulation (GDPR)’, that aims to protect the citizens of the EU nations from data and privacy breaches. Due to the implementation of such stringent data protection laws, the organizations in the region are making huge investments in data security.

Download sample copy of this report: https://www.psmarketresearch.com/marketanalysis/blockchain-in-healthcare-market/report-sample Therefore, because of the numerous benefits offered by the blockchain solutions such as data integrity, trust, and data security, they are being increasingly adopted by the organizations working in the healthcare industry across the world. Furthermore, the technology is receiving huge investments from both public and private organizations around the world, owing to its huge potential in the healthcare domain. For instance, Akiri, a blockchain start-up operating in the health industry received an investment worth $10.0 million from Health2047, which is an American Medical Association (AMA)-funded firm.

Clinical data exchange and interoperability, prescription drug abuse, drug supply chain management, drug discovery and clinical trials, and claims adjudication and billing management are the major categories present under the application segment of the blockchain in healthcare market. Out of these, the clinical data exchange and interoperability category had the highest share in the market in the

past, on account of the ability of the blockchain technology to potentially revolutionise the methods and processes by which clinical information and data are stored and shared in the healthcare domain.

Browse full report at: https://www.psmarketresearch.com/marketanalysis/blockchain-in-healthcare-market In coming years, the blockchain in healthcare market is predicted to demonstrate the fastest growth in the Asia-Pacific (APAC) region, growing at a CAGR of more than 70.0% from 2018 to 2023. This is attributed to the increasing adoption of blockchain solutions in APAC countries and the rising requirement of the technology in drug supply chain management and clinical data exchange and interoperability processes. Furthermore, many companies are making huge investments in the technology in the region, thereby boosting the growth of the market in the region.

Thus, the market will prosper all over the world in the future years, on account of the rising adoption of blockchain solutions in the healthcare industry, growing requirement of the blockchain technology in clinical data exchange and interoperability process, and the soaring demand for advanced security solutions in the healthcare domain.

Š P&S Intelligence. All rights reserved

3

Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications.

All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners.

An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.

Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 ©P&SIntelligence.Allrightsreserved

4